Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood

Cardile Sabrina; Candusso Manila; Papadatou Bronislava; Bracci Fiammetta; Knafelz Daniela; Torre Giuliano

首页> 外文期刊>European journal of gastroenterology and hepatology >Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood

【24h】

Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood

机译：英夫利昔单抗在童年时期炎性肠病治疗原发性硬化性胆管炎中的缺乏疗效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European journal of gastroenterology and hepatology》 |2017年第6期|共1页
作者
Cardile Sabrina; Candusso Manila; Papadatou Bronislava; Bracci Fiammetta; Knafelz Daniela; Torre Giuliano;
展开▼
作者单位

Bambino Gesu Pediat Hosp Hepatol Gastroenterol &

Nutr Unit Piazza St Onofrio 4 I-00165 Rome;

Bambino Gesu Pediat Hosp Hepatol Gastroenterol &

Nutr Unit Piazza St Onofrio 4 I-00165 Rome;

Bambino Gesu Pediat Hosp Hepatol Gastroenterol &

Nutr Unit Piazza St Onofrio 4 I-00165 Rome;

Bambino Gesu Pediat Hosp Hepatol Gastroenterol &

Nutr Unit Piazza St Onofrio 4 I-00165 Rome;

Bambino Gesu Pediat Hosp Hepatol Gastroenterol &

Nutr Unit Piazza St Onofrio 4 I-00165 Rome;

Bambino Gesu Pediat Hosp Hepatol Gastroenterol &

Nutr Unit Piazza St Onofrio 4 I-00165 Rome;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood [J] . Cardile Sabrina, Candusso Manila, Papadatou Bronislava, European journal of gastroenterology and hepatology . 2017,第6期

机译：英夫利昔单抗在童年时期炎性肠病治疗原发性硬化性胆管炎中的缺乏疗效
2. Case Control Cohort Study of Cancer Rates in Synchronous Primary Sclerosing Cholangitis and Inflammatory Bowel Disease Versus Patients With Inflammatory Bowel Disease Alone [J] . Liu K., Wang R., Kariyawasam V., Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association . 2015,第7期

机译：同期原发性硬化性胆管炎和炎性肠病与单发炎性肠病患者癌症发病率的病例对照队列研究
3. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease [J] . Christensen B., Micic D., Gibson P. R., Alimentary pharmacology & therapeutics. . 2018,第6期

机译：Vedolizumab患者同时发生的原发性胆管炎和炎症性肠病患者不会改善肝脏生物化学，但对肠病安全有效
4. Primary sclerosing cholangitis and inflammatory bowel disease: when and how do they relate to each other? [C] . E. SCHRUMPF, K. M. BOBERG Falk Liver Week . 2004

机译：原发性硬化性胆管炎和炎症肠道疾病：它们何时以及如何互相相关？
5. Efficacy of the Specific Carbohydrate Diet for the Treatment of Patients with Active, Severe, Biologic-Refractory Inflammatory Bowel Disease [D] . Dabbah, Eliane. 2020

机译：特定碳水化合物饮食治疗活性，严重，生物难治性炎症肠病患者的疗效
6. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis. [O] . H Zetterquist, U Broomé, K Einarsson, 1992

机译：原发性硬化性胆管炎和慢性炎症性肠病中的HLA II类基因：瑞典硬化性胆管炎患者中没有HLA-DRw52a关联。
7. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis. [O] . Zetterquist, H, Broomé, U, Einarsson, K, 1992

机译：原发性硬化性胆管炎和慢性炎症性肠病中的HLA II类基因：瑞典硬化性胆管炎患者中没有HLA-DRw52a关联。

Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood

著录项

相似文献

相关主题

期刊订阅